>>Signaling Pathways>> GPCR/G protein>> Angiotensin Receptor>>Allisartan isoproxil

Allisartan isoproxil

Catalog No.GC68638

알리사르탄 이소프록실(ALS-3)은 경구용으로 효과적이고 선택적인 혈관 긴장 호르몬 II형 1 수용체(Angiotensin II Type 1)의 비펩타이드 억제제입니다. 알리사르탄 이소프록실은 혈압 강하제입니다. 알리사르탄 이소프록실은 혈관 긴장 호르몬-알도스테론 시스템과 산화 스트레스를 억제할 수 있습니다. 알리사르탄 이소프록실은 혈압을 낮추고 장기를 보호하여 뇌혈관 손상을 예방할 수 있습니다. 알리사르탄 이소프록실(80-320 mg/kg/d)은 쥐 모델에서 간 기관에 대한 독성을 나타냅니다.

Products are for research use only. Not for human use. We do not sell to patients.

Allisartan isoproxil Chemical Structure

Cas No.: 947331-05-7

Size 가격 재고 수량
5mg
US$419.40
재고 있음
10mg
US$630.00
재고 있음
25mg
US$1,139.40
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of Allisartan isoproxil

Cas No. 947331-05-7 SDF
Formula C27H29ClN6O5 M.Wt 553.01
Solubility DMSO : 100 mg/mL (180.83 mM; ultrasonic and warming and heat to 60°C) Storage 4°C, protect from light
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Allisartan isoproxil

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.8083 mL 9.0414 mL 18.0829 mL
5 mM 0.3617 mL 1.8083 mL 3.6166 mL
10 mM 0.1808 mL 0.9041 mL 1.8083 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of Allisartan isoproxil

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

리뷰

Review for Allisartan isoproxil

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Allisartan isoproxil

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.